Targeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Early-onset epileptic encephalopathy (EE) presents a significant diagnostic challenge.
• Understanding the genetic underpinnings of EE is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the genetic basis of early-onset epileptic encephalopathy (EE) using a targeted next-generation sequencing (NGS) approach.
• To identify causative mutations in a cohort of sporadic and familial EE cases.

Main Methods:

• Targeted next-generation sequencing (NGS) was employed using a custom gene panel of 16 genes associated with EE.
• Thirty patients with early-onset EE were analyzed.
• Detected mutations were classified as definite or potential causal, and their inheritance patterns (de novo or familial) were assessed.

Main Results:

• Genetic analysis identified nine definite and three potential causal mutations in 40% (12 out of 30) of the EE cases.
• The mutation detection rate was higher in patients from non-consanguineous families (55.5%) compared to consanguineous families (16.6%).
• Eight of the 12 identified mutations were de novo.

Conclusions:

• Targeted NGS is an effective diagnostic tool for identifying genetic variants in early-onset epileptic encephalopathy.
• The findings support the channelopathy theory of epilepsy, particularly for de novo mutations in isolated patients.
• Consanguineous families presented a lower diagnostic yield with this specific gene panel approach.